Clearmind Medicine Inc. (CMND) stock
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$4.62−0.33 (-6.67%)
Close on Nov 12, 2026Market cap $730.31KP/E –Yield –
Clearmind Medicine enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Clearmind Medicine's enterprise value was -$11.41M on Nov 11, 2026, against $34.85M a year earlier. Over the last 5 years it ranged from -$11.41M to $1.39B, with a median of $41.19M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$11.41M | -256.3% |
| 2025 | Dec 31, 2025 | $7.30M | -53.7% |
| 2024 | Dec 31, 2024 | $15.78M | +266.1% |
| 2023 | Dec 29, 2023 | $4.31M | -98.7% |
| 2022 | Dec 30, 2022 | $333.60M | -49.9% |
| 2021 | Dec 31, 2021 | $665.26M | – |
See a number that looks wrong?